Compare TFIN & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TFIN | ALMR |
|---|---|---|
| Founded | 1981 | N/A |
| Country | United States | United States |
| Employees | 1450 | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | N/A | 2026 |
| Metric | TFIN | ALMR |
|---|---|---|
| Price | $79.79 | $25.83 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $66.20 | N/A |
| AVG Volume (30 Days) | 253.0K | ★ 382.4K |
| Earning Date | 04-21-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.27 | N/A |
| Revenue Next Year | $11.31 | N/A |
| P/E Ratio | $66.31 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $46.43 | $21.58 |
| 52 Week High | $80.57 | $29.43 |
| Indicator | TFIN | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 63.96 | 58.22 |
| Support Level | $60.93 | $24.26 |
| Resistance Level | $80.47 | $29.06 |
| Average True Range (ATR) | 2.56 | 1.87 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 93.70 | 32.77 |
Triumph Financial Inc is a financial holding company based in the United States. Along with its subsidiaries, the company operates in four reportable segments: Banking, Factoring, Payments, and Intelligence. The Banking segment, which generates maximum revenue, includes the operations of TBK Bank, offering traditional banking services. The Factoring segment provides working capital solutions to the trucking industry through the purchase of invoices generated by carriers at a discount. The Payments segment provides payment, audit, and other banking services for the over-the-road trucking industry, and the Intelligence segment operates to turn the over-the-road trucking data collected through the services offered into actionable insights for its customers.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.